A 51-year-old man who struggled with severe muscle spasms and difficulty walking for eight months has regained mobility following specialised treatment at Wockhardt Hospitals, Mumbai Central. Doctors successfully implanted an intrathecal baclofen pump after the patient showed significant improvement during an initial baclofen trial, helping restore his mobility and independence.
Patient Shows Improvement After Baclofen Trial
The patient approached Dr Sheetal Goyal, Consultant Neurologist at Wockhardt Hospitals, Mumbai Central, after experiencing persistent spinal flexor spasms and difficulty walking for several months. His condition had affected his ability to work and carry out everyday activities, significantly reducing his independence and quality of life.
Following a detailed clinical assessment, Dr Goyal identified the underlying cause of the symptoms and recommended a baclofen trial to evaluate the patient’s response to the medication.
Baclofen is used to manage spasticity, a condition characterised by excessive muscle stiffness and involuntary muscle contractions. For patients with severe spasticity who do not respond adequately to conventional treatments, intrathecal baclofen therapy offers an advanced treatment option.
Intrathecal Baclofen Pump Helps Improve Mobility
The patient showed a remarkable response to the baclofen trial, with significant improvement in muscle spasms and walking ability within just one hour. This positive response indicated that he could benefit from long-term intrathecal baclofen therapy.
Following the assessment, doctors successfully implanted an intrathecal baclofen pump. The device delivers medication directly into the cerebrospinal fluid surrounding the spinal cord, helping control excessive muscle activity and reduce stiffness and involuntary spasms.
Specialised Neurological Care Supports Recovery
Explaining the case, Dr Sheetal Goyal, Consultant Neurologist at Wockhardt Hospitals, Mumbai Central, said that the patient’s mobility, professional life and confidence had been significantly affected during the eight months of illness.
She emphasised that identifying the underlying cause of the symptoms was essential rather than continuing to manage them without addressing the root problem. The patient’s encouraging response to the baclofen trial helped the medical team determine that intrathecal baclofen therapy was an appropriate treatment option.
Dr Goyal also highlighted that the primary goal of the treatment was to help the patient regain independence and improve his quality of life.
Intrathecal baclofen therapy is recommended for carefully selected patients with severe spasticity. By delivering medication directly into the spinal fluid, the treatment can help reduce muscle stiffness, control involuntary spasms and improve mobility and comfort.
The case highlights the importance of accurate diagnosis, appropriate treatment evaluation and advanced neurological interventions in managing severe spasticity. It also demonstrates how specialised care can help patients with debilitating movement difficulties improve their mobility and quality of life. As per the company press release, the successful treatment at Wockhardt Hospitals, Mumbai Central, highlights the role of specialised neurological care and intrathecal baclofen therapy in managing severe spasticity and improving patient mobility.



















